Intelligence · Clinical pipeline
Metabolic & obesity R&D Pipeline
GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Quick answer
Metabolic & obesity: NovaPharmaNews indexes 744 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Top sponsors
- Takeda 75 programs
- NovoThirteen 61 programs
- First People's Hospital 38 programs
- Regeneron UK 35 programs
- Eli Lilly and 29 programs
- Chinese Academy of 26 programs
- United Therapeutics Europe 24 programs
- Boehringer Ingelheim 19 programs
- Anaxis Pharma 18 programs
- LEXICON PHARMACEUTICALS 16 programs
- George Institute for 15 programs
- Novo Nordisk A/S 14 programs
Pipeline programs
-
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial -
Trelagliptin
Takeda
Type 2 Diabetes
1 trial -
Trelagliptin
Takeda
Type 2 Diabetes Mellitus
2 trials -
Triple combination therapy group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Vortioxetine
Takeda
Type2 Diabetes
1 trial -
aflibercept 2.0 mg
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
alogliptin+pioglitazone
Takeda
Diabetes Mellitus, Type 2
1 trial -
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes
2 trials -
dapagliflozin
The First People's Hospital of Lianyungang
Diabetic Kidney Disease
1 trial -
glargine + exenatide
Hong Kong Baptist University
Type 2 Diabetes Mellitus
1 trial -
insulin detemir
Novo Nordisk A/S
Diabetes
2 trials -
insulin lispro injection, exenatide injection
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
metformin
Boehringer Ingelheim
Diabetes Mellitus, Type 2
1 trial -
pioglitazone
Takeda
Type 2 Diabetes
1 trial -
pioglitazone
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
pioglitazone
Takeda
Type 2 Diabetes Mellitus
4 trials -
pregabalin
Pfizer
Diabetic Neuropathy, Painful
1 trial -
premeal insulin lispro mixtures
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
25% Carbohydrate solution (CHO drinking)
Hospital Authority, Hong Kong
Type2diabetes
1 trial -
Cambridge Weight Plan
United Therapeutics Europe Ltd
Diabetes
1 trial -
Canagliflozin
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus With Complication
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Dapagliflozin
Hospital Authority, Hong Kong
Diabetes Mellitus, Type 2
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
EPCs plus PTA
The First People's Hospital of Lianyungang
Diabetic Foot
1 trial -
Early auto-mode
Century Therapeutics
Diabetes Mellitus Type 1 Pre-Existing
1 trial -
Experimental group
The First People's Hospital of Lianyungang
Overweight or Obesity
1 trial -
Fecal Microbiota Transplantation (FMT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 1 Diabetes
1 trial -
Fosinopril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Fresh organic vegetables
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial -
GLP-1 Receptor Agonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Short Bowel Syndrome (SBS)
1 trial -
Glimepiride
Takeda
Type 2 Diabetes
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
Huangqi Guizhi Wuwu decoction
The First People's Hospital of Lianyungang
Diabetic Nephropathies
1 trial -
Insulin
The First People's Hospital of Lianyungang
Gestational Diabetes
1 trial -
Iron Isomaltoside injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
KY20220825-04
The First People's Hospital of Lianyungang
Diabetes
1 trial -
Kefir peptide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Kunxian capsule
The First People's Hospital of Lianyungang
Diabetic Nephropathy
1 trial -
Lang Qingata
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NASH
1 trial -
Low-fat milk group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Lubiprostone
Takeda
Diabetes Mellitus, Type 1
1 trial -
Mango
BRIGHT MINDS BIOSCIENCES INC.
Overweight or Obesity
1 trial -
NUTBRA
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
Nut group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Olive oil
Universe Pharmaceuticals INC
Severe Obesity
1 trial -
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
PROGRAM
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity
1 trial
Frequently asked questions
How many metabolic & obesity pipeline programs are tracked?
744 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.